MiNK Therapeutics (6Q40.F) Q4 2025 Earnings

Nov 14Confirmed
Q1 2025
Q2 2025
Q3 2025
Q4 2025
-0.91
-0.75
-0.6
-0.44

Details

Expected EPS
-0.7355565
Actual EPS
-0.559195
Surprise EPS
0.18
Surprise Percent
+23.98%

Description

⁨MiNK Therapeutics⁩ (⁦6Q40.F⁩) has reported earnings of ⁦-0.559195⁩ per share for ⁦Q4 2025⁩.

0 Comments

Share your thoughts